Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Tim Behrens is among the laureates and finalists of the 2018 Blavatnik Awards for Young Scientists in the United Kingdom, announced today by the Blavatnik Family Foundation and the New York Academy of Sciences.

Image courtesy of Nick Irving

One laureate in each of the three Blavatnik Awards categories—Life Sciences, Physical Sciences & Engineering, and Chemistry—will each receive a prize of US$100,000, and two finalists in each category will each receive US$30,000. The Blavatnik Awards in the UK are the largest unrestricted cash prizes available exclusively to young scientists in the UK.

Professor Timothy Behrens of the Nuffield Department of Clinical Neurosciences has been named as a Life Sciences Finalist. Professor Behrens investigates the biology of the brain that underlies human behaviour. By combining mathematical models with behavioural experiments and neural recordings, he has uncovered at a cellular level how the brain stores abstract information about relationships between things in the world, and how we use this mental map in decision-making. His discoveries have applications in neural network computing and artificial intelligence, but also on our understanding of cognition and mental health.

Read more on the University website

Similar stories

Labelling proteins through the diet gives new insights into how collagen-rich tissues change as we age

A new study, published in eLife, uses advanced tissue analysis technology to show how the incorporation of new proteins changes in bone and cartilage with age.

Drug could help diabetic hearts recover after heart attack - Oxford research

Researchers at the University of Oxford have identified a drug that could ultimately help improve heart function in people with diabetes who have heart attacks.

Largest ever global study of tuberculosis identifies genetic causes of drug resistance

Using cutting-edge genomic sequencing techniques, researchers at the University of Oxford have identified almost all the genomic variation that gives people resistance to 13 of the most common tuberculosis (TB) drug treatments.

Peter Horby receives prestigious award for outstanding service to public health

The Faculty of Public Health (FPH) has awarded its prestigious Alwyn Smith Prize to Professor Sir Peter Horby (Nuffield Department of Medicine) for 2020/2021 in recognition of his outstanding service to public health as a global leader in epidemic science.

Six new Fellowships announced as part of Oxford-Bristol Myers Squibb Fellowships Programme

The Oxford - Bristol Myers Squibb (BMS) Fellowships Programme continued to demonstrate significant progress over the last year, despite the challenges associated with the global pandemic, including restricted lab access and work from home guidance. Today, we are pleased to announce six new Oxford-BMS Fellowships for 2021.

Researchers set out steps to address mental health effects of the pandemic on young people

Researchers have outlined 14 steps that schools, mental health services and policymakers can take to help children and young people whose mental health has been affected by the COVID-19 pandemic.